Duckett v. SCP 2006-C23-202, LLC

225 F. Supp. 3d 432, 2015 U.S. Dist. LEXIS 189395, 2015 WL 12991187
CourtDistrict Court, D. South Carolina
DecidedOctober 15, 2015
DocketCivil Action No.: 9:15-cv-2922-RMG
StatusPublished
Cited by1 cases

This text of 225 F. Supp. 3d 432 (Duckett v. SCP 2006-C23-202, LLC) is published on Counsel Stack Legal Research, covering District Court, D. South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Duckett v. SCP 2006-C23-202, LLC, 225 F. Supp. 3d 432, 2015 U.S. Dist. LEXIS 189395, 2015 WL 12991187 (D.S.C. 2015).

Opinion

ORDER

Richard Mark Gergel, United States District Court Judge

This matter comes before the court on Plaintiffs motion to remand (Dkt. No. 10), Plaintiffs motion to strike (Dkt. No. 14), and Defendant Palmetto Pharmacy Enterprises, LLC’s motion to dismiss (Dkt. No. 23). For the reasons below, this Court denies Plaintiffs motion to remand, dismisses Defendants South Carolina CVS Pharmacy, LLC and Palmetto Pharmacy, denies Plaintiffs motion to strike as moot, and denies Defendant Palmetto Pharmacy’s motion to dismiss as moot.

I. Background

Plaintiffs complaint states that he was prescribed Risperdal as a young child to help him sleep and for other psychiatric problems. The drug allegedly made Plaintiff lethargic and caused him to develop female-type breasts (gynecomastia). Defendants South Carolina CVS Pharmacy, LLC and Palmetto Pharmacy (the “Pharmacy Defendants”) filled his prescriptions during this period, which spanned from 2006-2009. Ortho-McNeil Janssen and Johnson & Johnson (the “Pharmaceutical Defendants”) manufactured and sold the drug. (Dk. No. 1-1 at 2-3).

Plaintiff initiated this action on June 19, 2015, by filing suit against Defendants in the Court of Common Pleas in Hampton County, South Carolina. (Dkt. No. 1-1). His original complaint alleged causes of action for negligence, strict liability, breach of warranties, and collateral estop-pel.

On July 27, 2015, the Pharmaceutical Defendants filed a notice of removal. (Dkt. No. 1). Although Plaintiff and the Pharmacy Defendants are South Carolina residents, the Pharmaceutical Defendants claim that removal is proper because Plaintiff fraudulently joined the Pharmacy Defendants. On August 14, 2015, Plaintiff filed an amended complaint that dropped the strict products liability claim against the Pharmacy Defendants and added a negligence claim against them. (Dkt. No 9). On August 18, 2015, Plaintiff filed a motion to remand. (Dkt. No.10).

On August 20, 2015, Defendant CVS Pharmacy filed an answer to the amended complaint. (Dkt, No. 12). Plaintiff then filed a motion to strike CVS Pharmacy’s answer as untimely, arguing that Defendant CVS Pharmacy never responded to the initial complaint or the notice of removal. (Dkt. No. 14). Finally, Defendant Palmetto Pharmacy filed a motion to dismiss for failure to state a claim, alleging that Plaintiff failed to satisfy certain statutory requirements for bringing a negligence claim and that Plaintiffs could not maintain an action for a breach of warran[435]*435ty against a pharmacy because pharmacies are service providers, not sellers. (Dkt. No. 23 and 23-1).

II. Motion to Remand

Plaintiff has filed a motion to remand the case to state court. (Dkt. No. 10). As the removing party, defendants bear the burden of demonstrating that federal jurisdiction is proper. Mulcahey v. Columbia Organic Chemicals Co., 29 F.3d 148, 151 (4th Cir. 1994). Here, the Pharmaceutical Defendants claim that federal jurisdiction is proper pursuant to 28 U.S.C. § 1332. (Dkt. No. 1 at 5).

Under 28 U.S.C. § 1332, federal district courts have original jurisdiction over any claim where the parties are diverse and the amount in controversy requirement is met. Although Plaintiffs’ complaints do not specify an amount-in-controversy, the Court is satisfied that his complained of medical injuries and the relief he seeks meet the $75,000 amount-in-controversy requirement. See Mattison v. Wal-Mart Stores. Inc., No. 6:10-CV-01739-JMC, 2011 WL 494395, at *l-*2 (D.S.C. Feb. 4, 2011) (noting that district courts in South Carolina have required removing defendants to show that the amount-in-controversy requirement was satisfied either to a legal certainty or a reasonable probability). Accordingly, the only question this court must answer to determine whether removal is proper is whether the parties are diverse.

Plaintiff and the Pharmacy Defendants are residents of South Carolina and the Pharmaceutical Defendants are foreign residents. Such absence of total diversity would typically be fatal to the removal of a diversity case because the district court would lack jurisdiction. But under the doctrine of fraudulent joinder, the district court may effectively “disregard, for jurisdictional purposes, the citizenship of certain nondiverse defendants, assume jurisdiction over a case, dismiss the nondiverse defendants, and thereby retain jurisdiction.” Mayes v. Rapoport, 198 F.3d 457, 461 (4th Cir. 1999).

“To show fraudulent joinder, the removing party must demonstrate either outright fraud in the plaintiffs pleading of jurisdictional facts or that there is no possibility that the plaintiff would be able to establish a cause of action against the instate defendant in state court.” Hartley v. CSX Transp., Inc., 187 F.3d 422, 424 (4th Cir. 1999) (internal quotation marks omitted) (emphasis in original). Because the Pharmaceutical Defendants do not allege fraud, this Court focuses on whether Plaintiff can establish a cause of action against the Pharmaceutical Defendants in South Carolina state court.

Plaintiffs original complaint1 alleged, at most, causes of action against the Pharmacy Defendants for strict liability and breach of warranties. (Dkt. No. 1-1 at 4). As a preliminary matter, Plaintiff cannot maintain a cause of action against the Pharmacy Defendants for strict liability. In Madison v. American Home Products Corporation, the Supreme Court of South Carolina held that because pharmacies are “health care providers” engaged in a service rather than sellers of a. good, they were relieved of strict products liability. 358.S.C. 449,595 S.E.2d 493, 495 (2004). By this same logic, this Court holds that, as a [436]*436service provider rather than a seller, a pharmacy cannot be held liable for a breach of warranty. That cause of action necessarily requires the existence of a buyer-seller relationship.2 See, e.g., S.C. Code Ann. § 36-2-314. Accordingly, this court holds that Plaintiffs original complaint does not maintain a cause of action against the Pharmacy Defendants. Therefore, the joinder of the Pharmacy Defendants is fraudulent, this Court has jurisdiction, the Pharmacy Defendants are dismissed, and Plaintiffs’ motion to remand is denied.

III. Motion to Strike

Plaintiff filed a motion to strike CVS Pharmacy’s answer to Plaintiffs amended complaint pursuant to Rule 12(f) of the Federal Rules of Civil Procedure. (Dkt. No. 14). The court denies this motion as moot based on its dismissal of Defendant CVS Pharmacy pursuant to the fraudulent joinder doctrine. But even if this court were not to find the motion to be moot, it would still deny the motion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kisner v. Medtronic Inc
D. South Carolina, 2021

Cite This Page — Counsel Stack

Bluebook (online)
225 F. Supp. 3d 432, 2015 U.S. Dist. LEXIS 189395, 2015 WL 12991187, Counsel Stack Legal Research, https://law.counselstack.com/opinion/duckett-v-scp-2006-c23-202-llc-scd-2015.